• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Harris C Martin was granted 7,356 shares, increasing direct ownership by 93% to 15,305 units (SEC Form 4)

    5/2/25 4:33:09 PM ET
    $CTEV
    Business Services
    Consumer Discretionary
    Get the next $CTEV alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    HARRIS C MARTIN

    (Last) (First) (Middle)
    C/O CLARITEV CORPORATION
    7900 TYSONS ONE PLACE, SUITE 400

    (Street)
    MCLEAN VA 22102

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Claritev Corp [ CTEV ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A common stock 04/30/2025 A(1) 7,356 A $0 15,305 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.
    Remarks:
    /s/ Kent Bartholomew, attorney-in-fact 05/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CTEV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Pres., CEO & Executive Chair Dalton Travis bought $100,823 worth of shares (5,252 units at $19.20), increasing direct ownership by 2% to 239,285 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      3/10/25 4:43:36 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $175,891 worth of shares (8,919 units at $19.72) (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      3/10/25 4:42:04 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Leadership Updates

    Live Leadership Updates

    See more
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Appoints Jason Kap to its Board of Directors

      Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generati

      5/1/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

      The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint. Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a pow

      5/7/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    SEC Filings

    See more
    • SEC Form S-8 filed by Claritev Corporation

      S-8 - Claritev Corp (0001793229) (Filer)

      5/9/25 8:05:24 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Claritev Corporation

      10-Q - Claritev Corp (0001793229) (Filer)

      5/9/25 7:40:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      5/8/25 6:04:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Financials

    Live finance-specific insights

    See more

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0

      4/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Director Kap Jason Lamar was granted 7,356 shares (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:39:27 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Kap Jason Lamar

      3 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:37:20 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Director Klapstein Julie D was granted 7,356 shares, increasing direct ownership by 89% to 15,634 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:36:05 PM ET
      $CTEV
      Business Services
      Consumer Discretionary